Stryker Orthopaedics has agreed to pay at least $1.43 billion to settle lawsuits brought by patients who allege injuries from defective metal-on-metal hip devices. The global settlement resolves claims involving the Rejuvenate and ABG II modular hip implants manufactured by Stryker Orthopaedics.
Stryker has settled lawsuits filed by four patients who alleged injuries from defective hip implants manufactured by the company.
Attorney for Defective Hip Implant Patients Urges FDA to Increase Regulation of All Metal-on-Metal Devices
Phoenix attorney Van O'Steen has asked the federal Food and Drug Administration (FDA) to expand its existing regulation of all metal-on-metal (MOM) hip implant devices. O'Steen's law firm represents patients throughout the United States who have been seriously harmed by the failure of DePuy, BioMet, Stryker and Wright implants.
On July 6, 2012, Stryker Orthopaedics announced that it was recalling certain hip device components, including the Rejuvenate. The Rejuvenate device is a modular-neck stem used in hip replacements. It is associated with corrosion and fretting, which can cause pain and swelling. The problems have forced some patients to undergo painful revision surgeries to remove the dangerous device.